Dental Implant Candidacy: Who Qualifies and Who May Not

Dental implant candidacy is determined by a convergence of anatomical, systemic, and behavioral factors that collectively predict whether a titanium fixture will successfully integrate with living bone. Not every patient presenting with tooth loss meets the threshold for implant placement, and the boundaries between qualified and disqualified are rarely absolute. Understanding how clinicians assess these criteria — and how the U.S. Food and Drug Administration classifies implant devices within this context — helps patients and providers navigate evaluation with realistic expectations.

Definition and scope

A dental implant candidate is a patient whose oral and systemic health profile supports the surgical placement of a root-form implant fixture and the subsequent biological process of osseointegration. The FDA classifies endosseous dental implants as Class II medical devices under 21 CFR Part 872.3640, subject to 510(k) premarket notification, which means device safety and effectiveness have been benchmarked against predicate devices — but the clinical decision of patient selection remains within the scope of licensed dental professionals.

Candidacy evaluation addresses three primary dimensions: skeletal readiness (jaw bone volume and density), systemic health status, and oral environment quality. A patient may satisfy two of the three dimensions and still require preliminary treatment — such as bone grafting — before implant surgery becomes viable. The overview of dental implants on this site provides broader context for where candidacy sits within the full treatment arc.

How it works

Candidacy determination follows a structured clinical pathway that typically unfolds across four phases:

Radiographic assessment — Periapical radiographs and cone beam computed tomography (CBCT) scans quantify available bone height and width. The American Academy of Implant Dentistry identifies a minimum of approximately 1 mm of bone surrounding a placed implant as a structural requirement, with most clinicians seeking at least 10 mm of vertical bone height in the posterior mandible to avoid inferior alveolar nerve proximity.
Systemic health review — Medical history screening flags conditions that alter healing capacity, immune response, or bone metabolism. The American Dental Association's oral health resources identify uncontrolled diabetes, active chemotherapy, and bisphosphonate therapy as factors warranting heightened scrutiny.
Periodontal evaluation — Active periodontal disease in residual dentition is a disqualifying condition until resolved. Bacterial loads associated with untreated periodontitis migrate to implant surfaces and increase peri-implantitis risk, a condition documented by the American Academy of Periodontology as affecting an estimated 10% to 47% of implant patients depending on diagnostic criteria used (AAP Position Paper on Peri-Implant Diseases).
Behavioral and lifestyle screening — Smoking, nocturnal bruxism, and medication profiles are assessed as modifiable or fixed risk variables. The interaction between implants and certain medications is complex enough to warrant a dedicated clinical review, covered at dental implants and medications.

Common scenarios

Straightforward candidates are generally non-smoking adults with fully developed jaws (skeletal maturity typically achieved by age 18 in females and age 21 in males), adequate bone volume, controlled systemic health, and good oral hygiene compliance. Single tooth implant replacement in this population carries documented 10-year survival rates exceeding 95% in peer-reviewed literature including the ITI (International Team for Implantology) consensus reports.

Conditionally qualified candidates include:

Diabetic patients — Type 2 diabetes does not automatically exclude candidacy. Research published in the Journal of Dental Research and referenced by the National Institute of Dental and Craniofacial Research (NIDCR) indicates that well-controlled diabetics (HbA1c below 7%) show implant survival rates comparable to non-diabetic populations, while poorly controlled diabetics face elevated failure risk. Detailed criteria are covered at dental implants for diabetics.
Older adults — Age alone is not a contraindication. Bone quality and systemic comorbidities, not chronological age, drive the assessment. The specific considerations for this population are detailed at dental implants for seniors.
Patients with insufficient bone — Insufficient ridge volume is addressable through augmentation procedures. A sinus lift procedure can restore posterior maxillary height, and horizontal ridge augmentation can widen a resorbed mandible to meet the threshold required for standard-diameter implants.

Patients who may not qualify include those with:

Active bisphosphonate or anti-RANKL therapy, which suppresses osteoclast activity and is associated with medication-related osteonecrosis of the jaw (MRONJ), as defined by the American Association of Oral and Maxillofacial Surgeons (AAOMS Position Paper on MRONJ)
Uncontrolled bleeding disorders or anticoagulation protocols incompatible with surgical intervention
Active head-and-neck radiation therapy targeting the jaw, which compromises vascular supply and healing capacity
Unresolved heavy smoking habits — tobacco use is associated with implant failure rates roughly double those of non-smokers, a relationship detailed at dental implants and smoking

Decision boundaries

The distinction between absolute and relative contraindications is clinically significant. Absolute contraindications — conditions where implant placement is categorically unsafe regardless of modification — are comparatively rare and include recent jaw irradiation without hyperbaric oxygen protocol and active MRONJ. Relative contraindications describe conditions that elevate risk but can be mitigated through treatment sequencing, medication management, or alternative implant configurations such as mini dental implants where bone volume is marginal.

The regulatory context for dental implants shapes how manufacturers communicate device indications and contraindications in product labeling, and those labeled contraindications carry weight in the clinical candidacy conversation. When candidacy remains unclear after initial evaluation, structured protocols for a dental implant second opinion provide a defined pathway to additional clinical judgment without duplicating the full diagnostic workup.

Bone density thresholds — often classified using the Misch Bone Quality scale (BQ-1 through BQ-4) — map directly onto implant design selection, drilling protocol, and loading timeline. The specific measurements that define each density category are covered at bone density requirements for dental implants.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)